Published in Carcinogenesis on January 01, 1981
Polyamine levels in normal human skin. A comparative study of pure epidermis, pure dermis, and suction blister fluid. Arch Dermatol Res (1983) 0.88
Epidemiological basis for clinical diagnosis of childhood malaria in endemic zone in West Africa. Lancet (1991) 5.11
Impact of EGFR expression on colorectal cancer patient prognosis and survival. Ann Oncol (2005) 3.34
Population study of dihydropyrimidine dehydrogenase in cancer patients. J Clin Oncol (1994) 2.94
Determination of oestrogen receptors by enzyme immunoassay. Technical differences between laboratories and their consequences. Eur J Cancer (1994) 2.80
Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer. J Clin Oncol (1993) 2.07
Management of hypertension in angiogenesis inhibitor-treated patients. Ann Oncol (2009) 2.06
Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy. Ann Oncol (2010) 1.91
Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop. Malar J (2004) 1.90
Phase I trial of 5-day continuous venous infusion of oxaliplatin at circadian rhythm-modulated rate compared with constant rate. J Natl Cancer Inst (1990) 1.81
The influence of food on the pharmacokinetics of CGP 6140 (amocarzine) after oral administration of a 1200 mg single dose to patients with onchocerciasis. Br J Clin Pharmacol (1990) 1.76
Human herpesvirus 8-associated hemophagocytic lymphohistiocytosis in human immunodeficiency virus-infected patients. Clin Infect Dis (2003) 1.72
Pharmacokinetics of sunitinib in hemodialysis. Ann Oncol (2008) 1.70
Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas. Head Neck (1991) 1.66
Effect of indinavir on HIV-related wasting. AIDS (1998) 1.59
Metabolic modulation induced by chronic hypoxia in rats using a comparative proteomic analysis of skeletal muscle tissue. J Proteome Res (2007) 1.55
P53 determination alongside classical prognostic factors in node-negative breast cancer: an evaluation at more than 10-year follow-up. Ann Oncol (2000) 1.53
Correlation between dihydropyrimidine dehydrogenase activity in peripheral mononuclear cells and systemic clearance of fluorouracil in cancer patients. Cancer Res (1992) 1.53
Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: establishment, characterization and response to cytotoxic treatment. Eur J Cancer Clin Oncol (1988) 1.50
A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil. Eur J Cancer (1994) 1.49
Dihydropyrimidine dehydrogenase circadian rhythm in mouse liver: comparison between enzyme activity and gene expression. Eur J Cancer (2003) 1.48
Cytosine deaminase/5-fluorocytosine-based vaccination against liver tumors: evidence of distant bystander effect. J Natl Cancer Inst (1999) 1.48
Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity. J Clin Oncol (1995) 1.47
Regulation of interleukin 2 synthesis by cAMP in human T cells. J Immunol (1987) 1.47
Severe interaction between methotrexate and a macrolide-like antibiotic. J Natl Cancer Inst (1993) 1.40
Combined effects of bevacizumab with erlotinib and irradiation: a preclinical study on a head and neck cancer orthotopic model. Br J Cancer (2008) 1.33
Influence of epidermal growth factor receptor (EGFR), p53 and intrinsic MAP kinase pathway status of tumour cells on the antiproliferative effect of ZD1839 ("Iressa"). Br J Cancer (2002) 1.29
Bone substitutes in orthopaedic surgery: from basic science to clinical practice. J Mater Sci Mater Med (2014) 1.27
Known variant DPYD alleles do not explain DPD deficiency in cancer patients. Pharmacogenetics (2000) 1.24
Clinical and pharmacokinetic evidence of a life-threatening interaction between methotrexate and ketoprofen. Lancet (1986) 1.22
Intestinal permeability in liver cirrhosis: relationship with severe septic complications. Eur J Gastroenterol Hepatol (1999) 1.21
Determination of microsatellite instability, p53 and K-RAS mutations in hepatic metastases from patients with colorectal cancer: relationship with response to 5-fluorouracil and survival. Int J Cancer (2001) 1.18
Epidermal growth factor receptor signaling in colorectal cancer: preclinical data and therapeutic perspectives. Ann Oncol (2005) 1.18
Dose reduction without loss of efficacy for 5-fluorouracil and cisplatin combined with folinic acid. In vitro study on human head and neck carcinoma cell lines. Br J Cancer (1991) 1.16
Pharmacological background of EGFR targeting. Ann Oncol (2004) 1.15
Severe fluorouracil toxicity in a patient with dihydropyrimidine dehydrogenase deficiency. J Natl Cancer Inst (1993) 1.14
Epidermal growth factor receptor and labeling index are independent prognostic factors in glial tumor outcome. Clin Cancer Res (1998) 1.11
Role of the HER2 [Ile655Val] genetic polymorphism in tumorogenesis and in the risk of trastuzumab-related cardiotoxicity. Ann Oncol (2007) 1.11
Oxaliplatin: pharmacokinetics and chronopharmacological aspects. Clin Pharmacokinet (2000) 1.09
Activation of nuclear factor kappaB through the IKK complex by the topoisomerase poisons SN38 and doxorubicin: a brake to apoptosis in HeLa human carcinoma cells. Cancer Res (2001) 1.08
5-FU therapeutic monitoring with dose adjustment leads to an improved therapeutic index in head and neck cancer. Br J Cancer (1989) 1.08
DI2ADEM: an adaptive hypermedia designed to improve access to relevant medical information. Proc AMIA Symp (2000) 1.07
Improving knowledge navigation with adaptive hypermedia. Med Inform Internet Med (2000) 1.07
IL-1 signaling for IL-2 production in T cells involves a rise in phosphatidylserine synthesis. J Immunol (1988) 1.06
Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms: relationships with 5-fluorouracil sensitivity. Br J Cancer (2004) 1.06
Sequence-dependent effects of ZD1839 ('Iressa') in combination with cytotoxic treatment in human head and neck cancer. Br J Cancer (2002) 1.06
Incidence of Hajj-associated febrile cough episodes among French pilgrims: a prospective cohort study on the influence of statin use and risk factors. Clin Microbiol Infect (2009) 1.06
The E2 molecule (CD99) specifically triggers homotypic aggregation of CD4+ CD8+ thymocytes. J Immunol (1995) 1.05
Clinical impact of pharmacokinetically-guided dose adaptation of 5-fluorouracil: results from a multicentric randomized trial in patients with locally advanced head and neck carcinomas. Clin Cancer Res (1998) 1.04
Clinical pharmacokinetic study of 5-FU in continuous 5-day infusions for head and neck cancer. Cancer Chemother Pharmacol (1986) 1.04
Radiological classification of optic pathway gliomas: experience of a modified functional classification system. Br J Radiol (2008) 1.02
Ribonucleoprotein (RNP) soluble nuclear antigen: demonstration of its reaction with serum antibodies by counter-immunoelectrophoresis and further partial characterization. J Immunol Methods (1977) 1.02
Comparative study of gamma glutamyl transferase, alkaline phosphatase and its alpha 1 isoenzyme as biological indicators of liver metastases. Clin Chim Acta (1981) 1.01
Evidence for CSF accumulation of 5-methyltetrahydrofolate during repeated courses of methotrexate plus folinic acid rescue. Br J Cancer (1989) 1.00
Age-related difference in tamoxifen disposition. Clin Pharmacol Ther (1996) 0.99
The DNA labelling index: a prognostic factor in node-negative breast cancer. Breast Cancer Res Treat (1987) 0.99
Epidermal growth factor receptor double targeting by a tyrosine kinase inhibitor (Iressa) and a monoclonal antibody (Cetuximab). Impact on cell growth and molecular factors. Br J Cancer (2005) 0.98
Search for the optimal schedule for the oxaliplatin/5-fluorouracil association modulated or not by folinic acid: preclinical data. Clin Cancer Res (1998) 0.98
Epidermal growth factor receptor expression in 780 breast cancer patients: a reappraisal of the prognostic value based on an eight-year median follow-up. Ann Oncol (2001) 0.98
Importance of mevalonate-derived products in the control of HMG-CoA reductase activity and growth of human lung adenocarcinoma cell line A549. Int J Cancer (1993) 0.97
Human interleukin 2. Detection at the picomolar level by sandwich enzyme immunoassay. J Immunol Methods (1987) 0.97
Analysis of the dinucleotide repeat polymorphism in the epidermal growth factor receptor (EGFR) gene in head and neck cancer patients. Ann Oncol (2005) 0.97
[Utilization of mosquitoes impregnated with deltamethrin in the battle against malaria]. Parassitologia (1984) 0.97
Biodistribution study of 99mTc-labeled LDL in B16-melanoma-bearing mice. Visualization of a preferential uptake by the tumor. Int J Cancer (1993) 0.97
Lack of contribution of dihydrofluorouracil and alpha-fluoro-beta-alanine to the cytotoxicity of 5'-deoxy-5-fluorouridine on human keratinocytes. Anticancer Drugs (2004) 0.96
Supra-additive antitumor effect of sunitinib malate (SU11248, Sutent) combined with docetaxel. A new therapeutic perspective in hormone refractory prostate cancer. J Cancer Res Clin Oncol (2007) 0.96
Clinical and radiographic results of ACL reconstruction: a 5- to 7-year follow-up study of outside-in versus inside-out reconstruction techniques. Knee Surg Sports Traumatol Arthrosc (2001) 0.96
Enhanced antitumor activity of 5-fluorouracil in combination with 2'-deoxyinosine in human colorectal cell lines and human colon tumor xenografts. Clin Cancer Res (2000) 0.96
The value of serum alkaline phosphatase alpha 1 isoenzyme in the diagnosis of liver metastases. Preliminary results. Biomedicine (1979) 0.96
[Telecobalt therapy of cancer of the canal at the Institut Gustave-Roussy]. Ann Radiol (Paris) (1966) 0.95
Alpha-fetoprotein: the major high-affinity estrogen binder in rat uterine cytosols. Proc Natl Acad Sci U S A (1976) 0.95
EGFR in colorectal cancer: more than a simple receptor. Ann Oncol (2006) 0.95
Dual inhibition of EGFR and VEGFR pathways in combination with irradiation: antitumour supra-additive effects on human head and neck cancer xenografts. Br J Cancer (2007) 0.95
Graft healing after anterior cruciate ligament reconstruction in rabbits. Clin Orthop Relat Res (1997) 0.95
Prognostic value of total cathepsin D in breast tumors. A possible role in selection of chemoresistant patients. Breast Cancer Res Treat (1991) 0.95
Two high affinity estrogen binding proteins of different specificity in the immature rat uterus cytosol. Steroids (1974) 0.94
Link between dihydropyrimidine dehydrogenase activity in peripheral blood mononuclear cells and liver. Clin Cancer Res (1996) 0.93
Histological analysis of the coracoacromial arch: correlation between age-related changes and rotator cuff tears. Arthroscopy (1996) 0.93
In vitro chemosensitivity testing of Fotemustine (S 10036), a new antitumor nitrosourea. Cancer Chemother Pharmacol (1990) 0.93
PK/PD model of indisulam and capecitabine: interaction causes excessive myelosuppression. Clin Pharmacol Ther (2007) 0.92
[Risk factors for human African trypanosomiasis in the Bipindi region of Cameroon]. Med Trop (Mars) (2001) 0.92
Phase I and pharmacokinetic study of the association of capecitabine-cisplatin in head and neck cancer patients. Ann Oncol (2003) 0.92
Branched-chain keto-acids and pyruvate in blood: measurement by HPLC with fluorimetric detection and changes in older subjects. Clin Chem (2000) 0.92
Dihydropyrimidine dehydrogenase: a tumoral target for fluorouracil modulation. Clin Cancer Res (1995) 0.92
Circadian rhythm-varying plasma concentration of 5-fluorouracil during a five-day continuous venous infusion at a constant rate in cancer patients. Cancer Res (1988) 0.91
Evaluation of biomarkers in caged fishes and mussels to assess the quality of waters in a bay of the NW Mediterranean Sea. Environ Pollut (1998) 0.91
Meniscal allografts: cryopreservation vs deep-frozen technique. An experimental study in goats. Knee Surg Sports Traumatol Arthrosc (1997) 0.91
Phase II trial of cisplatin, fluorouracil, and pure folinic acid for locally advanced head and neck cancer: a pharmacokinetic and clinical survey. J Clin Oncol (1995) 0.91
Very high endothelin plasma levels in patients with 5-FU cardiotoxicity. Ann Oncol (1992) 0.91
Human CD5 signaling and constitutive phosphorylation of C-terminal serine residues by casein kinase II. J Immunol (1998) 0.90
Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study. Clin Microbiol Infect (2014) 0.90
Epidermal growth factor receptor expression and suramin cytotoxicity in vitro. Eur J Cancer (1990) 0.90
Simultaneous micro measurement of steroid receptors in breast cancer. Br J Cancer (1983) 0.90
Prospects for the application of fast neutrons in cancer therapy. Radiobiological bases and survey of the clinical data. Bull Cancer (1986) 0.90
Regulation by sphingomyelinase and sphingosine of Ca2+ signals elicited by CD3 monoclonal antibody, thapsigargin, or ionomycin in the Jurkat T cell line. J Biol Chem (1994) 0.90
[Imported malaria at the Marseilles Hôpital-Nord, France: a prospective study on 352 cases between 2001 and 2003]. Med Mal Infect (2005) 0.90
Chymotryptic-type protease inhibitors block the increase in Ca2+ and Il-2 production in activated Jurkat T cells. J Immunol (1989) 0.90
An integrated approach to distance learning with digital video in the French-speaking Virtual Medical University. Int J Med Inform (2007) 0.90
New directions in the treatment of colorectal cancer: a look to the future. Eur J Cancer (2000) 0.89